Inventor · disambiguated record
Gary T. Wang
Also filed as: WANG GARY · WANG GARY T
44 granted patents·20 pending applications·699 citations·filing 1996–2024
98Inventor score
Top patents by PatentIndex Score
64 records- 0198US8546399B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2010·Granted Oct 1, 2013·100 cites·24 claims
- 0297US9174982B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Nov 3, 2015·38 cites·7 claims
- 0397US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0497US8580794B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Nov 12, 2013·44 cites·3 claims
- 0597US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0697US8557983B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Oct 15, 2013·44 cites·2 claims
- 0796US9034875B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 19, 2015·19 cites·1 claims
- 0896US9029404B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 12, 2015·19 cites·1 claims
- 0994US9326508B2(S)-3′-methyl-abscisic acid and esters thereofVALENT BIOSCIENCES CORP·Filed 2015·Granted May 3, 2016·5 cites·9 claims
- 1094US9073855B2BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·2 claims
- 1194US9045420B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jun 2, 2015·11 cites·1 claims
- 1294US7772231B2Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitorsABBOTT LAB·Filed 2006·Granted Aug 10, 2010·68 cites·20 claims
- 1391US9303025B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Apr 5, 2016·11 cites·4 claims
- 1491US8338466B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesKUNZER AARON R·Filed 2010·Granted Dec 25, 2012·15 cites·6 claims
- 1591US6455571B1Inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Sep 24, 2002·60 cites·115 claims
- 1690US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 1790US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 1889US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 1988US9872492B2(S)-abscisic acid derivatives for thinningVALENT BIOSCIENCES CORP·Filed 2016·Granted Jan 23, 2018·2 cites·14 claims
- 2087US9447015B1(S)-2′-vinyl-abscisic acid derivativesVALENT BIOSCIENCES CORP·Filed 2016·Granted Sep 20, 2016·5 cites·30 claims
- 2186US2025019364A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2024·Application pending·0 cites
- 2284US6787542B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2001·Granted Sep 7, 2004·19 cites·27 claims
- 2383US2024043404A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2023·Application pending·0 cites
- 2482US11897864B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2022·Granted Feb 13, 2024·0 cites·27 claims
- 2582US10729135B2Methods of controlling pests using terpendolesVALENT BIOSCIENCES LLC·Filed 2018·Granted Aug 4, 2020·1 cites·6 claims
- 2680US10945443B2Tolypocladium album strainVALENT BIOSCIENCES LLC·Filed 2018·Granted Mar 16, 2021·1 cites·15 claims
- 2780US9877480B2(S)-abscisic acid derivatives for enhanced grape colorationVALENT BIOSCIENCES CORP·Filed 2016·Granted Jan 30, 2018·1 cites·9 claims
- 2879US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 2975US8354422B2Pyrimidine inhibitors of kinase activityABBOTT LAB·Filed 2010·Granted Jan 15, 2013·2 cites·18 claims
- 3075US2022315555A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2021·Application pending·0 cites
- 3175US2021221789A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2020·Application pending·0 cites
- 3274US8486933B2Pyrimidine inhibitors of kinase activityWANG GARY T·Filed 2010·Granted Jul 16, 2013·3 cites·22 claims
- 3374US6593314B1Neuraminidase inhibitorsABBOTT LAB·Filed 2000·Granted Jul 15, 2003·8 cites·15 claims
- 3473US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 3570US2020231566A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 3669US7129247B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2004·Granted Oct 31, 2006·3 cites·26 claims
- 3769US6831096B2Inhibitors of neuraminidasesABBOTT LAB·Filed 2002·Granted Dec 14, 2004·3 cites·9 claims
- 3869US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3968US2019119247A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2018·Application pending·0 cites
- 4066US10299476B23′-substituted-abscisic acid derivativesVALENT BIOSCIENCES LLC·Filed 2017·Granted May 28, 2019·0 cites·1 claims
- 4164US11497214B2Methods of controlling pests using terpendolesVALENT BIOSCIENCES LLC·Filed 2020·Granted Nov 15, 2022·0 cites·11 claims
- 4264US9156856B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2012·Granted Oct 13, 2015·0 cites·6 claims
- 4363US7056925B2Urea kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jun 6, 2006·2 cites·20 claims
- 4463US2017158666A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2016·Application pending·0 cites
- 4563US2024215582A1Methods of controlling plant pathogensVALENT BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 4662US2012190688A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2012·Application pending·0 cites
- 4761US9051315B2Imidazopyridines as a novel scaffold for multi-targeted kinase inhibitionBA-MAUNG NWE Y·Filed 2010·Granted Jun 9, 2015·1 cites·4 claims
- 4861US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 4960US9781930B23′-substituted-abscisic acid derivativesVALENT BIOSCIENCES CORP·Filed 2015·Granted Oct 10, 2017·0 cites·4 claims
- 5059US2015329541A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary T. Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →